Protecting newborns against pertussis: The value of vaccinating during pregnancy

Expert Review of Vaccines

Volumn 14, Issue 8, 2015, Pages 1051-1053

  Vilajeliu, Alba ^a   García Basteiro, Alberto L ^a,b   Bayas, José M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Manhiça Health Research Center   (Mozambique)

Author keywords

child health; coverage; maternal immunization; neonatal pertussis; pregnancy; vaccination; whooping cough

Indexed keywords

MATERNAL ANTIBODY; PERTUSSIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

DECISION MAKING; EPIDEMIC; FEMALE; GESTATIONAL AGE; HEALTH CARE PERSONNEL; HUMAN; IMMUNOGENICITY; INCIDENCE; INFANT MORTALITY; INFECTION PREVENTION; INFORMED CONSENT; MORBIDITY; NEWBORN; NEWBORN DISEASE; PERTUSSIS; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; THIRD TRIMESTER PREGNANCY; VACCINATION; INFANT; WHOOPING COUGH;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; WHOOPING COUGH;

EID: 84937119168     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.1050386     Document Type: Review

References (20)

1. Grupo de Trabajo Tos Ferina 2012 de la Ponencia de Programas y Registro de Vacunaciones. Revisio-n del programa de vacunacio-n frente a tos ferina en espana. comisio-n de salud publica del consejo interterritorial del sistema nacional de salud. ministerio de sanidad, servicios sociales e igualdad. 2013. Available from: http://msc. es/profesionales/saludPublica/prev Promocion/vacunaciones/docs/TosFerina.pdf
2. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic 2010. J Pediatr 2012;161(6):1091-6
3. The Joint Committee on Vaccination and Immunisation. Temporary programme of pertussis (whooping cough) vaccination of pregnant women. 2012. Available from: www.gov.uk/government/uploads/system/uploads/attachment-data/file/126972/CMOPertussis-27-09-2012-FINAL.pdf
4. Burns DL, Meade BD, Messionnier NE. Pertussis resurgence: perspectives from the working group meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge. J Infect Dis 2014; 209(Suppl 1):S32-5
5. McGirr A, Fisman D. Duration of pertussis immunity after DTaP immunization: a meta-Analysis. Pediatrics 2015;135(2): 331-43
6. SAGE pertussis Working Group. WHO SAGE pertussis working group. background paper sage. 2014. Available from: www.who. int/immunization/sage/meetings/2014/april/1-Pertussis-background-FINAL4-web.pdf
7. Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005; 24(5 Suppl):S62-5
8. Kendrick P, Thompson M, Elderling G. Immunity response of mothers and babies to injections of pertussis vaccine during pregnancy. Int J Gynecol Obstet 1945;70: 25-8
9. Vilajeliu A, Gonce-A, Lo-pez M, et al. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine Elsevier Ltd 2015;33(8): 1056-62
10. Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants. JAMA 2014;311(17):1760-9
11. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013;56(4): 539-44
12. Taranger J, Trollfors B, Lagergard T, et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000;181(3):1010-13
13. Heininger U, Riffelmann M, Bar G, et al. The protective role of maternally derived antibodies against bordetella pertussis in young infants. Pediatr Infect Dis J 2013; 32(6):695-8
14. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immuniza MMWR Morb Mortal Wkly Rep 2011 60 41 1424-6
15. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014;349: g4219
16. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96(3 II Suppl):580-4
17. Hardy-Fairbanks A, Pan S, Decker M, et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013;32(11):1257-60
18. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384(9953):1521-8
19. Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis 2015;60(3):333-7
20. Wiley KE, Cooper SC, Wood N, Leask J. Understanding pregnant womens attitudes and behavior toward influenza and pertussis vaccination. Qual Health Res 2015;25(3): 360-70